Elena Rantou was awarded her Ph.D. in Statistics from American University, Washington DC. She has worked in academia and as a statistical consultant for many years. She joined FDA/CDER in 2013. Her work focuses on generic drugs review as well as research related to determining bioequivalence of locally acting drugs, classification / data mining for data fraud detection and similarity of pharmacokinetic profiles.